Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2014
Effects of genetic deletion of endogenous opioid system components on the reinstatement of cocaine-seeking behavior in miceJavier Gutiérrez-Cuesta, Aurelijus Burokas, Samantha Mancino, et al.Adicciones|January 20, 2026
Loss of eating control and cognitive flexibility: Involvement of gut microbiotaSolveiga Samulenaite, Aurelijus Burokas, José Manuel Fernández-Real, et al.Plos One|November 14, 2013
Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumptionAlvaro Llorente-Berzal, Emma Puighermanal, Aurelijus Burokas, et al.Addiction Biology|December 29, 2017
Extinction and reinstatement of an operant responding maintained by food in different models of obesityAurelijus Burokas, Elena Martín-García, Jose Espinosa-Carrasco, et al.Psychopharmacology|December 17, 2010
New operant model of reinstatement of food-seeking behavior in miceElena Martín-García, Aurelijus Burokas, Elzbieta Kostrzewa, et al.Journal of Neurochemistry|March 21, 2014
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASBAurelijus Burokas, Elena Martín-García, Javier Gutiérrez-Cuesta, et al.Addiction Biology|January 11, 2018
Time-course and dynamics of obesity-related behavioral changes induced by energy-dense foods in miceJose Espinosa-Carrasco, Aurelijus Burokas, Marta Fructuoso, et al.Biological Psychiatry|March 1, 2017
Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in MiceAurelijus Burokas, Silvia Arboleya, Rachel D Moloney, et al.Menopause (New York, N.Y.)|December 17, 2024
Associations of reproductive hormones and stress-related factors with menopausal symptomsIeva Brimienė, Monika Šiaudinytė, Erik Ilkevič, et al.Journal of Neurochemistry|December 24, 2009
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabantElena Martín-García, Aurelijus Burokas, Miquel Martín, et al.Pageof 6